References
- Al-Hajj M, Clarke MF (2004). Self-renewal and solid tumor stem cells. Oncogene, 23, 7274-82. https://doi.org/10.1038/sj.onc.1207947
- Arsura M and Cavin LG (2005). Nuclear factor-kappaB and liver carcinogenesis. Cancer Lett, 229, 157-69. https://doi.org/10.1016/j.canlet.2005.07.008
- Kang JS, Wanibuchi H, Morimura K, et al (2007). Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo. Cancer Res, 67, 11141-6. https://doi.org/10.1158/0008-5472.CAN-07-1369
- Kenyon J, Gerson SL (2007). The role of DNA damage repair in aging of adult stem cells. Nucleic Acids Res, 35, 7557-65. https://doi.org/10.1093/nar/gkm1064
- Litvinov SV, Velders MP, Bakker HA, et al (1994). Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J Cell Biol, 125, 437-46. https://doi.org/10.1083/jcb.125.2.437
- Maetzel D, Denzel S, Mack B, et al (2009). Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol, 11, 162-71. https://doi.org/10.1038/ncb1824
- Peto R, Gray R, Brantom P, et al (1991). Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: a detailed dose-response study. Cancer Res, 51, 6415-51.
- Pitot HC, Dragan YP, Teeguarden J, et al (1996). Quantitation of multistage carcinogenesis in rat liver. Toxicol Pathol, 24, 119-128. https://doi.org/10.1177/019262339602400116
- Sell S and Dunsford HA (1989). Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol, 134, 1347-63.
- Turner R, Lozoya O, Wang Y, et al (2011). Human hepatic stem cell and maturational liver lineage biology. Hepatology, 53, 1035-45. https://doi.org/10.1002/hep.24157
- van der Gun BT, Melchers LJ, Ruiters MH, et al (2010). EpCAM in carcinogenesis: the good, the bad or the ugly. Carcinogenesis, 31, 1913-21. https://doi.org/10.1093/carcin/bgq187
- Verna L, Whysner J, Williams GM (1996). N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther, 71, 57-81. https://doi.org/10.1016/0163-7258(96)00062-9
- Visvader JE, Lindeman GJ (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer, 8, 755-68. https://doi.org/10.1038/nrc2499
- Wicha MS, Liu S, Dontu G (2006). Cancer stem cells: an old idea--a paradigm shift. Cancer Res, 66, 1883-1890; discussion 1895-86. https://doi.org/10.1158/0008-5472.CAN-05-3153
- Yamashita T, Forgues M, Wang W, et al (2008). EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res, 68, 1451-61. https://doi.org/10.1158/0008-5472.CAN-07-6013
- Yamashita T, Ji J, Budhu A, et al (2009). EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology, 136, 1012-24. https://doi.org/10.1053/j.gastro.2008.12.004
- Yoon SM, Gerasimidou D, Kuwahara R, et al (2011). Epithelial cell adhesion molecule (EpCAM) marks hepatocytes newly derived from stem/progenitor cells in humans. Hepatology, 53, 964-73. https://doi.org/10.1002/hep.24122
Cited by
- Preventive Effect of Hydrazinocurcumin on Carcinogenesis of Diethylnitrosamine-induced Hepatocarcinoma in Male SD Rats vol.15, pp.5, 2014, https://doi.org/10.7314/APJCP.2014.15.5.2115